Eballena, Nena A.
HRN: 17-55-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
LEVOFLOXACIN 500MG (TAB)
06/06/2025
06/12/2025
NGT
500mg
OD
CAP MR, R/I HAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes